AKR1B1 expression is increased in rectal, hepatocellular, lung, breast, cervical, and ovarian cancer [38,43,44,45,46] and decreased in colorectal and endometrial cancer [28,47,48,49]. Here, AKR1B1 is linked to ovarian carcinoma.